Tandem Mass Spectrometry in Newborn Screening
- 1 January 2002
- journal article
- Published by Wolters Kluwer Health in The Endocrinologist
- Vol. 12 (1) , 50-57
- https://doi.org/10.1097/00019616-200201000-00011
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Fatty Acid Oxidation DisordersAnnual Review of Physiology, 2002
- Multiple Acyl-CoA-Dehydrogenase Deficiency (MADD): Use of Acylcarnitines and Fatty Acids to Monitor the Response to Dietary TreatmentPediatric Research, 2001
- Newborn screening with tandem mass spectrometry: 12 months' experience in NSW AustraliaActa Paediatrica, 1999
- Medium-chain acyl-CoA dehydrogenase deficiency: Sudden and unexpected death of a 45 year old womanGenetics in Medicine, 1999
- Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: a model for clinical mass spectrometry in the next millenniumActa Paediatrica, 1999
- The introduction of newborn screening for phenylketonuriaEuropean Journal of Pediatrics, 1996
- The first treatment of phenylketonuriaEuropean Journal of Pediatrics, 1996
- Medium Chain Acyl-CoA Dehydrogenase Deficiency in Pennsylvania: Neonatal Screening Shows High Incidence and Unexpected Mutation FrequenciesPediatric Research, 1995
- Ethylmalonic aciduria: an organic acidemia with CNS involvement and vasculopathyBrain & Development, 1994
- Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolismJournal of Inherited Metabolic Disease, 1990